Payment overview · 2025
General Payments
$5,909.82
55 reported records · 11 companies
Healthcare provider profile · identity verified
Avinash Mesipam, M.D.
Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology · SAINT LOUIS, MO · NPI 1427495316
Verified facts
What the public records show
CMS Open Payments records show Avinash Mesipam, M.D. received $5,909.82 in general payments during 2025 across 55 reported records.
Penumbra, Inc. accounted for 51.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 26 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $3,060.53 | 51.8% | 17 | 2025 |
| Balt USA, LLC | Unresolved — no canonical attribution shown | $1,173.18 | 19.9% | 4 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $812.66 | 13.8% | 17 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $364.13 | 6.2% | 7 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $173.20 | 2.9% | 2 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$159.49 | 2.7% | 2 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $45.54 | 0.8% | 2 | 2025 |
| Mozarc Medical US LLC | Unresolved — no canonical attribution shown | $37.73 | 0.6% | 1 | 2025 |
| Baylis Medical Technologies Inc. | Unresolved — no canonical attribution shown | $35.90 | 0.6% | 1 | 2025 |
| MicroVention, Inc. | Unresolved — no canonical attribution shown | $25.28 | 0.4% | 1 | 2025 |
| Inari Medical, Inc. | Unresolved — no canonical attribution shown | $22.18 | 0.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Travel and Lodging | $3,330.98 | 12 |
| Food and Beverage | $2,578.84 | 43 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $2,625.51 | 13 | 2025 |
Source payment records
|
|||||
| Carrier Delivery Catheter Normalized: carrier delivery catheter |
Device | Balt USA, LLC | $1,173.18 | 4 | 2025 |
Source payment records
|
|||||
| Optima Coil System Normalized: optima coil system |
Device | Balt USA, LLC | $357.22 | 3 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $349.16 | 3 | 2025 |
Source payment records
|
|||||
| TRUFILL Normalized: trufill |
Device | DePuy Synthes Sales Inc. | $207.79 | 4 | 2025 |
Source payment records
|
|||||
| TARGET Normalized: target |
Device | Stryker Corporation | $206.70 | 2 | 2025 |
Source payment records
|
|||||
| OPTABLATE Normalized: optablate |
Device | Stryker Corporation | $176.20 | 3 | 2025 |
Source payment records
|
|||||
| EMBOTRAP Normalized: embotrap |
Device | DePuy Synthes Sales Inc. | $168.62 | 2 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Inari Medical, Inc., Stryker Corporation | $152.74 | 5 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Inari Medical, Inc., Stryker Corporation | $152.74 | 5 | 2025 |
Source payment records
|
|||||
| EMBOLD Fibered Normalized: embold fibered |
Device | Boston Scientific Corporation | $146.37 | 1 | 2025 |
Source payment records
|
|||||
| CEREPAK UNIFORM Normalized: cerepak uniform |
Device | DePuy Synthes Sales Inc. | $134.16 | 2 | 2025 |
Source payment records
|
|||||
| TREVO Normalized: trevo |
Device | Stryker Corporation | $112.49 | 1 | 2025 |
Source payment records
|
|||||
| VANTAGE ANTERIOR FIXATION SYSTEM Normalized: vantage anterior fixation system |
Device | Medtronic, Inc. | $108.08 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra Coil 400 Normalized: penumbra coil 400 |
Device | Penumbra, Inc. | $85.86 | 1 | 2025 |
Source payment records
|
|||||
| EVOLVE Normalized: evolve |
Device | Stryker Corporation | $57.07 | 2 | 2025 |
Source payment records
|
|||||
| SOLITAIRE X Normalized: solitaire x |
Device | Medtronic, Inc. | $51.41 | 1 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $48.34 | 2 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $40.48 | 1 | 2025 |
Source payment records
|
|||||
| PALINDROME Normalized: palindrome |
Device | Mozarc Medical US LLC | $37.73 | 1 | 2025 |
Source payment records
|
|||||
| AXS VECTA 71 Normalized: axs vecta 71 |
Device | Stryker Corporation | $27.21 | 1 | 2025 |
Source payment records
|
|||||
| Cryoablation needles Normalized: cryoablation needles |
Device | Boston Scientific Corporation | $26.83 | 1 | 2025 |
Source payment records
|
|||||
| ZOOM REPERFUSION CATHETER Normalized: zoom reperfusion catheter |
Device | Imperative Care, Inc | $25.63 | 1 | 2025 |
Source payment records
|
|||||
| SOFIA 6F-131CM STR Normalized: sofia 6f 131cm str |
Device | MicroVention, Inc. | $25.28 | 1 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $19.91 | 1 | 2025 |
Source payment records
|
|||||
| PROTRIEVE SHEATH Normalized: protrieve sheath |
Device | Stryker Corporation | $13.61 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Brilinta | Ticagrelor | 15 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 14 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $5,909.82 · 55 records | Penumbra, Inc. | ARTIX MT, AXS VECTA 71, CEREPAK UNIFORM, CLOTTRIEVER BOLD CATHETER, CT THROMBECTOMY SYSTEM KIT, Carrier Delivery Catheter, Cryoablation needles, EMBOLD Fibered, EMBOTRAP, EVOLVE, FLOWTRIEVER CATHETER, S, Indigo System, OPTABLATE, Optima Coil System, PALINDROME, PROTRIEVE SHEATH, Penumbra Coil 400, Penumbra System, SOFIA 6F-131CM STR, SOLITAIRE X, SYMPHONY CATHETER, TARGET, TREVO, TRUFILL, VANTAGE ANTERIOR FIXATION SYSTEM, ZOOM REPERFUSION CATHETER | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error